4-Methylpseudoproline analogues of cyclolinopeptide A: Synthesis, structural analysis and evaluation of their suppressive effects in selected immunological assays

• Published in: Peptides (New York, N.Y. : 1980) N.Y. : 1980), 2020-10, Vol.132, p.170365-170365, Article 170365
• Main Authors: Katarzyńska, Joanna, Artym, Jolanta, Kochanowska, Iwona, Jędrzejczak, Karol, Zimecki, Michał, Lisowski, Marek, Wieczorek, Robert, Piotrowski, Łukasz, Marcinek, Andrzej, Zabrocki, Janusz, Jankowski, Stefan
• Format: Article
• Language: English
• Subjects: 4-methylpseudoproline; Antibody response to SRBC; Apoptosis; Cyclolinopeptide A; Jurkat T cells; Splenocyte proliferation
• ISSN: 0196-9781; 1873-5169
• DOI: 10.1016/j.peptides.2020.170365

•Two analogues of cyclolinopeptide A modified with (R)-4-methylpseudoproline exhibit high antiproliferative activity.•The replacement of Pro3 in CLA by (R)-(αMe)Ser(ΨPro) increases the conformational freedom of such an analogue.•The analogue modified in position 3 with (R)-4-methylpseudoproline more strongly elevates the expression of Fas molecule.•The mentioned analogues may find application in controlling some immune disorders and progression of some cancers. The synthesis of new analogues of cyclolinopeptide A (CLA) and their linear precursors modified with (R)- and (S)-4-methylpseudoproline in the Pro3-Pro4 fragment are presented. The peptides were tested in comparison with cyclosporine A (CsA) in concanavalin A (Con A) and pokeweed mitogen (PWM)-induced mouse splenocyte proliferation and in secondary humoral immune response in vitro to sheep erythrocytes (SRBC). Their effects on expression of selected signaling molecules in the Jurkat T cell line were also determined. In addition, the structural features of the peptides, applying nuclear magnetic resonance and circular dichroism, were analyzed. The results showed that only peptides 7 and 8 modified with (R)-4-methylpseudoproline residue (c(Leu1-Val2-(R)-(αMe)Ser(ΨPro)3-Pro4-Phe5-Phe6-Leu7-Ile8-Ile9) and c(Leu1-Val2-Pro3-(R)-(αMe)Ser(ΨPro)4-Phe5-Phe6-Leu7-Ile8-Ile9), respectively) strongly suppressed mitogen-induced splenocyte proliferation and the humoral immune response, with peptide 8 being more potent. Likewise, peptide 8 more strongly elevated expression of Fas, a proapoptotic signaling molecule in Jurkat cells. We postulate that the increased biological activity of peptide 8, compared to the parent molecule and other studied peptides, resulted from its more flexible structure, found on the basis of both CD and NMR studies. CD and NMR spectra showed that replacement of Pro3 by (R)-(αMe)Ser(¬Pro) caused much greater conformational changes than the same replacement of the Pro4 residue. Such a modification could lead to increased conformational freedom of peptide 8, resulting in a greater ability to adopt a more compact structure, better suited to its putative receptor. In conclusion, peptide 8 is a potent immune suppressor which may find application in controlling immune disorders.